Willis Investment Counsel’s NRC Health Common Stock NRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.38M | Buy |
434,785
+210,147
| +94% | +$3.9M | 0.45% | 67 |
|
|
2026
Q1 | $3.81M | Buy |
224,638
+41,412
| +23% | +$704K | 0.21% | 76 |
|
|
2025
Q4 | $3.44M | Buy |
183,226
+2,920
| +2% | +$44.1K | 0.18% | 85 |
|
|
2025
Q3 | $2.3M | Sell |
180,306
-693
| -0.4% | -$10.4K | 0.13% | 84 |
|
|
2025
Q2 | $3.04M | Buy |
180,999
+115,221
| +175% | +$1.56M | 0.18% | 77 |
|
|
2025
Q1 | $842K | Buy |
65,778
+10,531
| +19% | +$169K | 0.06% | 91 |
|
|
2024
Q4 | $975K | Sell |
55,247
-906
| -2% | -$17.2K | 0.06% | 86 |
|
|
2024
Q3 | $1.28M | Buy |
56,153
+21,451
| +62% | +$485K | 0.08% | 80 |
|
|
2024
Q2 | $796K | Buy |
34,702
+4,063
| +13% | +$125K | 0.06% | 84 |
|
|
2024
Q1 | $1.21M | Buy |
30,639
+2,734
| +10% | +$108K | 0.08% | 83 |
|
|
2023
Q4 | $1.1M | Sell |
27,905
-1,094
| -4% | -$45.8K | 0.08% | 86 |
|
|
2023
Q3 | $1.29M | Sell |
28,999
-4,634
| -14% | -$202K | 0.1% | 80 |
|
|
2023
Q2 | $1.46M | Sell |
33,633
-2,040
| -6% | -$89.7K | 0.1% | 83 |
|
|
2023
Q1 | $1.55M | Buy |
35,673
+1,966
| +6% | +$86.8K | 0.1% | 81 |
|
|
2022
Q4 | $1.26M | Sell |
33,707
-3,768
| -10% | -$146K | 0.08% | 84 |
|
|
2022
Q3 | $1.49M | Sell |
37,475
-30,921
| -45% | -$1.14M | 0.11% | 86 |
|
|
2022
Q2 | $2.62M | Buy |
68,396
+13,360
| +24% | +$483K | 0.16% | 84 |
|
|
2022
Q1 | $2.18M | Buy |
55,036
+2,393
| +5% | +$93.7K | 0.12% | 85 |
|
|
2021
Q4 | $2.19M | Sell |
52,643
-3,563
| -6% | -$155K | 0.12% | 86 |
|
|
2021
Q3 | $2.37M | Buy |
56,206
+8,569
| +18% | +$431K | 0.14% | 86 |
|
|
2021
Q2 | $2.19M | Buy |
47,637
+45
| +0.1% | +$2.14K | 0.13% | 89 |
|
|
2021
Q1 | $2.23M | Buy |
47,592
+1,970
| +4% | +$95.7K | 0.14% | 91 |
|
|
2020
Q4 | $1.95M | Sell |
45,622
-597
| -1% | -$30.6K | 0.13% | 90 |
|
|
2020
Q3 | $2.27M | Sell |
46,219
-45
| -0.1% | -$2.49K | 0.2% | 82 |
|
|
2020
Q2 | $2.69M | Buy |
46,264
+706
| +2% | +$37.3K | 0.21% | 87 |
|
|
2020
Q1 | $2.07M | Buy |
45,558
+19,213
| +73% | +$1.15M | 0.17% | 90 |
|
|
2019
Q4 | $1.74M | Buy |
26,345
+1,103
| +4% | +$67.4K | 0.11% | 87 |
|
|
2019
Q3 | $1.46M | Sell |
25,242
-8,713
| -26% | -$540K | 0.1% | 90 |
|
|
2019
Q2 | $1.96M | Sell |
33,955
-306,595
| -90% | -$14.2M | 0.13% | 93 |
|
|
2019
Q1 | $22.5M | Buy |
340,550
+271,452
| +393% | +$10.6M | 1.55% | 19 |
|
|
2018
Q4 | $2.63M | Buy |
69,098
+965
| +1% | +$37.1K | 0.2% | 97 |
|
|
2018
Q3 | $2.63M | Buy |
68,133
+3,104
| +5% | +$118K | 0.18% | 91 |
|
|
2018
Q2 | $2.43M | Buy |
65,029
+14,724
| +29% | +$513K | 0.18% | 95 |
|
|
2018
Q1 | $1.47M | Buy |
50,305
+20,340
| +68% | +$682K | 0.11% | 105 |
|
|
2017
Q4 | $1.12M | Buy |
29,965
+11,625
| +63% | +$413K | 0.08% | 110 |
|
|
2017
Q3 | $691K | Sell |
18,340
-7,480
| -29% | -$235K | 0.05% | 115 |
|
|
2017
Q2 | $695K | Sell |
25,820
-16,205
| -39% | -$396K | 0.05% | 115 |
|
|
2017
Q1 | $828K | Sell |
42,025
-1,585
| -4% | -$29.3K | 0.06% | 119 |
|
|
2016
Q4 | $829K | Buy |
43,610
+2,740
| +7% | +$45.2K | 0.06% | 121 |
|
|
2016
Q3 | $666K | Hold |
40,870
| – | – | 0.05% | 118 |
|
|
2016
Q2 | $560K | Buy |
40,870
+11,080
| +37% | +$156K | 0.05% | 120 |
|
|
2016
Q1 | $463K | Buy |
+29,790
| New | +$437K | 0.04% | 121 |
|
Other funds holding NRC
QI
FMII
Willis Investment Counsel's NRC Position: Q2 2026 in Review
Willis Investment Counsel increased its NRC Health Common Stock (NRC) stake by 94% in Q2 2026, buying an estimated $3.9M and bringing the position to 434,785 shares worth $9.38M. The position accounts for 0.45% of the portfolio, ranked #67.
Willis Investment Counsel first reported a position in NRC in Q1 2016 and has held it in 42 quarters since. The position peaked at $22.5M in Q1 2019. 124 funds tracked by Wall St. Rank hold NRC as of Q2 2026.
- Willis Investment Counsel held 434,785 shares of NRC Health Common Stock worth $9.38M as of Q2 2026.
- Willis Investment Counsel bought 210,147 NRC Health Common Stock shares in Q2 2026, an estimated $3.9M.
- NRC Health Common Stock made up 0.45% of Willis Investment Counsel's portfolio in Q2 2026, its #67 holding.
- Willis Investment Counsel first reported a position in NRC Health Common Stock in Q1 2016 and has held it in 42 quarters since.
- Willis Investment Counsel's NRC Health Common Stock position peaked at $22.5M in Q1 2019.
- 124 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.
Based on Willis Investment Counsel's 13F filing for Q2 2026, filed 3 Aug 2026.